medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

1

Estimating the COVID-19 epidemic trajectory and

2

hospital capacity requirements in South West

3

England: a mathematical modelling framework

4

Ross D. Booton1, Louis MacGregor2,3, Lucy Vass1,2, Katharine J. Looker2,3,

5

Catherine Hyams4, Philip D. Bright5, Irasha Harding6, Rajeka Lazarus7, Fergus

6

Hamilton8, Daniel Lawson9, Leon Danon10, Adrian Pratt11, Richard Wood12,13, Ellen

7

Brooks-Pollock1,2,3,â€ , Katherine M.E. Turner1,2,3,13,â€ ,*

8
9

1Bristol

Veterinary School, University of Bristol, Bristol, UK

10

2Population

11

3NIHR

12

4Academic

13

5Immunology,

14

6Consultant

in Microbiology, University Hospitals Bristol, Bristol, UK

15

7Consultant

in Microbiology and Infectious Diseases, University Hospitals Bristol, Bristol, UK

16

8Infection

17

9School

18

10College

19

11Principal

20

12Head

21

13Health

22

â€ should

23

*Correspondence: katy.turner@bristol.ac.uk

Health Science Institute, Bristol Medical School, University of Bristol, Bristol, UK

Health Protection Research Unit in Behavioural Science and Evaluation
Respiratory Unit, Southmead Hospital, University of Bristol, Bristol, UK
Pathology Sciences, North Bristol NHS Trust, Bristol, UK

Science, Southmead Hospital, North Bristol NHS Trust, Bristol, UK

of Mathematics, University of Bristol, Bristol, UK
of Engineering, Mathematics and Physical Sciences, University of Exeter, Exeter, UK
BI Analyst Modelling and Analytics, NHS Bristol, North Somerset and South Gloucestershire CCG

of Modelling and Analytics, NHS Bristol, North Somerset and South Gloucestershire CCG
Data Research UK South-West of England Partnership

be considered joint senior author

24
25

Word count: 4014 (not including references, figures or tables)

26

Keywords: Mathematical model, COVID-19, hospital capacity, R value, epidemic

27

trajectory

NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

28

Abstract

29

Objectives: To develop a regional model of COVID-19 dynamics, for use in estimating

30

the number of infections, deaths and required acute and intensive care (IC) beds using

31

the South West of England (SW) as an example case.

32

Design: Open-source age-structured variant of a susceptible-exposed-infectious-

33

recovered (SEIR) deterministic compartmental mathematical model. Latin hypercube

34

sampling and maximum likelihood estimation were used to calibrate to cumulative

35

cases and cumulative deaths.

36

Setting: SW at a time considered early in the pandemic, where National Health

37

Service (NHS) authorities required evidence to guide localised planning and support

38

decision-making.

39

Participants: Publicly-available data on COVID-19 patients.

40

Primary and secondary outcome measures: The expected numbers of infected

41

cases, deaths due to COVID-19 infection, patient occupancy of acute and IC beds and

42

the reproduction (â€œRâ€) number over time.

43

Results: SW model projections indicate that, as of the 11th May 2020 (when

44

â€˜lockdownâ€™ measures were eased), 5,793 (95% credible interval, CrI, 2,003 â€“ 12,051)

45

individuals were still infectious (0.10% of the total SW England population, 95%CrI

46

0.04 â€“ 0.22%), and a total of 189,048 (95%CrI 141,580 â€“ 277,955) had been infected

47

with the virus (either asymptomatically or symptomatically), but recovered, which is

48

3.4% (95%CrI 2.5 â€“ 5.0%) of the SW population. The total number of patients in acute

49

and IC beds in the SW on the 11th May 2020 was predicted to be 701 (95%CrI 169 â€“

50

1,543) and 110 (95%CrI 8 â€“ 464) respectively. The R value in SW England was

51

predicted to be 2.6 (95%CrI 2.0 â€“ 3.2) prior to any interventions, with social distancing

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

52

reducing this to 2.3 (95%CrI 1.8 â€“ 2.9) and lockdown/ school closures further reducing

53

the R value to 0.6 (95CrI% 0.5 â€“ 0.7).

54

Conclusions: The developed model has proved a valuable asset for local and

55

regional healthcare services. The model will be used further in the SW as the

56

pandemic evolves, and â€“ as open source software â€“ is portable to healthcare systems

57

in other geographies.

58
59

Future work/ applications:

60

i.

Open-source modelling tool available for wider use and re-use.

61

ii.

Customisable to a number of granularities such as at the local, regional and

62
63

national level.
iii.

64
65

estimating unobservable quantities, e.g. asymptomatic population.
iv.

66
67
68
69
70

Supports a more holistic understanding of intervention efficacy through

While not presented here, future use of the model could evaluate the effect of
various interventions on transmission of COVID-19.

v.

Further developments could consider the impact of bedded capacity in terms
of resulting excess deaths.

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

71

Introduction

72

Since the initial outbreak in 2019 in Hubei Province, China, COVID-19, the

73

disease caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-

74

2), has gone on to cause a pandemic [1]. As of 11th May 2020, the Centre for Systems

75

Science and Engineering at Johns Hopkins University reports over 4,000,000

76

confirmed cases and 250,000 deaths globally [2]. National responses to the outbreak

77

have varied; from severe restrictions on human mobility alongside widespread testing

78

and contact tracing in China [3] to the comparatively relaxed response in Sweden,

79

where lockdown measures have not been enacted [4]. In the UK, advice to socially

80

distance if displaying symptoms was given on the 15th March, while school closures

81

and â€˜lockdownâ€™ measures were implemented from 23rd March onwards [5].

82

Mathematical modelling has been used to predict the course of the COVID-19

83

pandemic and to evaluate the effectiveness of proposed and enacted interventions [6â€“

84

11]. These models have been predominantly aimed at the national level and have

85

largely been based on epidemiological and biological data sourced from the initial

86

epidemic in Wuhan, China [12] and the first large outbreak in Lombardy, Italy [13].

87

In the UK, the epidemic escalated most rapidly in London [14] and the majority

88

of national modelling is seemingly driven by the trends in London, due to its large case

89

numbers and large population. One of the key issues facing NHS authorities is

90

planning for more localised capacity needs and estimating the timings of surges in

91

demand at a regional or healthcare system level. This is especially challenging given

92

the rapidly evolving epidemiological and biological data; the changes in COVID-19

93

testing availability (e.g. previously limited and changing eligibility requirements); the

94

uncertainty in the effectiveness of interventions in different contexts; significant and

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

95

uncertain time-lags between initial infection and hospitalisation or death; and different

96

regions being at different points in the epidemic curve [9]. South West England (SW)

97

is the region with the lowest number of total cases in England (as of 11th May 2020),

98

lagging behind the national data driven by the earlier epidemic in London [9,14].

99

COVID-19 results in a significant requirement for hospitalisation, and high

100

mortality amongst patients requiring admission to critical care (particularly amongst

101

those requiring ventilation) [15,16]. In the SW, the population is on average older than

102

in London [17] and is older than the UK as a whole (Table S1). Older age puts

103

individuals at elevated risk of requiring hospital care [18â€“20]. Consequently, we might

104

expect higher mortality and greater demand for beds in the SW than estimations output

105

from national models that may lack such granularity or risk sensitivity.

106

However, the SWâ€™s first case occurred around 2 weeks later than the first UK

107

case [14]; perhaps implying that the local SW epidemic may be more effectively

108

controlled due to a lower number of baseline cases (than the national average) at the

109

time national interventions were implemented, as well as reduced transmission due to

110

rurality. This sub-national analysis can support in mapping the local epidemic, planning

111

local hospital capacity outside of the main urban centres, and ensuring effective

112

mobilisation of additional support and resources if required. Should demand be lower

113

than expected, reliable forecasts could facilitate more effective use of available

114

resources through re-introducing elective treatments (that had initially been

115

postponed) and responding to other, non-COVID-19 sources of emergency demand.

116

In this study, taking into account the timeline of UK-wide non-pharmaceutical

117

interventions (social distancing, school closures/lockdown) we illustrate use of our

118

model in projecting estimates for the expected distributions of cases, deaths,

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

119

asymptomatic and symptomatic infections, and demand for acute and intensive care

120

(IC) beds. We present the model trajectories for SW England using publicly-available

121

data.

122
123

Methods

124

We developed a deterministic, ordinary differential equation model of the

125

transmission dynamics of COVID-19, including age-structured contact patterns, age

126

specific disease progression and demand for hospitalisation, both to acute and IC. We

127

then parameterised the model using available literature and calibrated the model to

128

data from the SW. The model is readily adapted to fit data at sub-regional (e.g. Clinical

129

Commissioning Group), regional or national level. Key assumptions of the model are

130

summarised in the supplementary information.

131

The model was developed in R and all code and links to source data are freely

132

available (github.com/rdbooton/bricovmod). The model is coded using package

133

deSolve, with contact matrices from package socialmixr, and sampling from package

134

lhs.

135

Model structure

136

The stages of COVID-19 included within this model are ğ‘º-susceptible, ğ‘¬-exposed (not

137

currently infectious, but have been exposed to the virus), ğ‘¨- asymptomatic infection

138

(will never develop symptoms), ğ‘°-symptomatic infection (consisting of pre-

139

symptomatic or mild to moderate symptoms), ğ‘¯-severe symptoms requiring

140

hospitalisation but not IC, ğ‘ª-very severe symptoms requiring IC, ğ‘¹-recovered and ğ‘«-

141

death. The total population is ğ‘µ = ğ‘º + ğ‘¬ + ğ‘¨ + ğ‘° + ğ‘¯ + ğ‘ª + ğ‘¹ + ğ‘« (Figure 1).

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

142

Each compartment ğ‘¿ğ’ˆ is stratified by age-group (0-4, 5-17, 18-29, 30-39, 40-

143

49, 50-59, 60-69, â‰¥70) where ğ‘¿ denotes the stage of COVID-19 (S,E,I,A,H,C,R,D) and

144

ğ’ˆ denotes the age group class of individuals. Age groups were chosen to capture key

145

social contact patterns (primary, secondary and tertiary education and employment)

146

and variability in hospitalisation rates and outcomes from COVID-19 especially in older

147

age groups. The total in each age group is informed by recent Office for National

148

Statistics (ONS) estimates [21].

149

Susceptible individuals become exposed to the virus at a rate governed by the

150

force of infection ğ€ğ’ˆ , and individuals are non-infectious in the exposed category. A

151

proportion ğœ¹ move from exposed to symptomatic infection and the remaining to

152

asymptomatic infection, both at the latent rate ğœ¼. Individuals leave both the

153

asymptomatic and symptomatic compartments at rate ğ. All asymptomatic individuals

154

eventually recover and there are no further stages of disease: the rate of leaving the

155

asymptomatic compartment is therefore equivalent to the infectious period, ğ. A

156

proportion of symptomatic individuals ğœ¸ğ’ˆ go on to develop severe symptoms which

157

require hospitalisation, but not intensive care. Once requiring hospitalisation, we

158

assume individuals are no longer infectious to the general population due to self-

159

isolation guidelines restricting further mixing with anyone aside from household

160

members (if unable to be admitted to hospital) or frontline NHS staff (if admitted to

161

hospital). Individuals move out of the acute hospitalised compartment at rate ğ†, either

162

through death, being moved to intensive care at rate ğ, or through recovery (all

163

remaining individuals). A proportion ğğ’ˆ of patients requiring IC will die at rate ğ, while

164

the rest will recover.

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

165

The model (schematic in Figure 1) is therefore described by the following differential

166

equations:
ğ‘‘ğ‘†"
= âˆ’ğœ†" ğ‘†"
ğ‘‘ğ‘¡

(1ğ‘)

ğ‘‘ğ¸"
= ğœ†" ğ‘†" âˆ’ ğœ‚ğ¸"
ğ‘‘ğ‘¡

(1ğ‘)

Susceptible ğ‘ºğ’ˆ
Exposed ğ‘¬ğ’ˆ

#$!

Asymptomatic ğ‘¨ğ’ˆ

#%

Infectious ğ‘°ğ’ˆ

bed ğ‘¯ğ’ˆ
Hospitalised in IC ğ‘ªğ’ˆ

#'!

Death ğ‘«ğ’ˆ

(1ğ‘)

#&!

(1ğ‘‘)

#%

Hospitalised in acute

Recovered ğ‘¹ğ’ˆ

= ğœ‚(1 âˆ’ ğ›¿)ğ¸" âˆ’ ğœ‡ğ´"

#%

= ğœ‚ğ›¿ğ¸" âˆ’ ğœ‡ğ¼"

ğ‘‘ğ»"
= ğœ‡ğ›¾" ğ¼" âˆ’ ğœŒğ»"
ğ‘‘ğ‘¡

(1ğ‘’)

ğ‘‘ğ¶"
= ğœŒğœ–ğ»" âˆ’ ğœ“ğ¶"
ğ‘‘ğ‘¡

(1ğ‘“)

= ğœ‡ğ´" + ğœ‡(1 âˆ’ ğ›¾" )ğ¼" +
(1 âˆ’ ğœ–)(1 âˆ’ ğœ…)ğœŒğ»" + S1 âˆ’ ğœ”" Uğœ“ğ¶"

(1ğ‘”)

ğ‘‘ğ·"
= (1 âˆ’ ğœ–)ğœ…ğœŒğ»" + ğœ”" ğœ“ğ¶"
ğ‘‘ğ‘¡

(1â„)

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

167
168

Figure 1: Compartmental flow model diagram depicting stages of disease and transitions between

169

states. Asymptomatic infection represents the number of people never showing symptoms, while

170

symptomatic infection includes all those who show pre-symptomatic / mild symptoms to those who show

171

more severe symptoms (pre-hospitalisation). Those who are hospitalised first occupy a non-IC bed

172

(acute bed) after which they can either move into IC, recover or die. Those in IC can either recover or

173

die at an increased rate compared to those in acute beds. This model does not capture those deaths

174

which occur outside of hospital as a result of COVID-19.

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

175

Contact patterns under national interventions

176

We assume the population is stratified into pre-defined age groups with age-

177

specific mixing pattern represented by a contact matrix ğ‘´ with an element of ğ’ğ’Šğ’‹

178

representing the contacts between someone of age group ğ’Š âˆˆ ğ‘® with someone in age

179

group ğ’‹ âˆˆ ğ‘®. The baseline contact matrix (with no interventions in place) is taken from

180

the POLYMOD survey conducted in the United Kingdom [22]. The contact pattern may

181

also be influenced by a range of interventions (social distancing was encouraged on

182

15th March 2020, schools were closed and lockdown occurred on 23rd March 2020).

183

We implement these interventions by assuming that the percentage of 0-18-year olds

184

attending school after the 23rd March 2020 was 5% (reducing all contacts between

185

school age individuals by 95%) and that social distancing reduced all contacts by 0-

186

50%. We take the element-wise minimum for each age groupâ€™s contact with another

187

age group from all active interventions (distancing, schools/lockdown). A study on

188

post-lockdown contact patterns (CoMix [11]) is used to inform contacts after lockdown

189

(first survey 24th March 2020, with an average of 73% reduction in daily contacts

190

observed per person compared to POLYMOD).

191

Moving between contact matrices of multiple interventions was implemented by

192

assuming a phased, linear decrease. After lockdown we vary a parameter (endphase)

193

to capture the time taken to fully adjust (across the population, on average) to the new

194

measures (allowed to vary from 1 to 31 days). This assumption represents the time

195

taken for individuals to fully adapt to new measures (and household transmission),

196

and is in line with data on the delay in the control of COVID-19 (reductions in hospital

197

admissions and deaths after lockdown) [23]. The parameter endphase can be

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

198

interpreted as accounting for the time taken to adjust to all interventions (and not just

199

lockdown).

200
201

The force of infection

202

The age-specific force of infection ğ€ğ’ˆ , depends on the proportion of the population who

203

are infectious (asymptomatic ğ‘¨ğ’ˆ and symptomatic ğ‘°ğ’ˆ only) and probability of

204

transmission ğœ·:

205

ğ´*
ğ¼*
ğœ†" = ğ›½ a ğ‘š*" c + e
ğ‘" ğ‘"

(2 )

*âˆˆ,

206

The basic reproduction number R0

207

The basic reproduction number ğ‘…- of COVID-19 is estimated to be 2.79 Â± 1.16 [24].

208

We include this estimate within our model by calculating the maximum eigenvalue of

209

the contact matrix ğ‘´, and allowing the transmission parameter to vary such that ğ‘…- is

210

equal to the maximum eigenvalue of ğ‘´ multiplied by the infectious period ğœ‡ and the

211

transmission parameter ğ›½. This gives the value for the initial basic reproduction

212

number ğ‘…- , which changes as the contact patterns change as lockdown and other

213

interventions are implemented.

214
215

Parameter estimates and data sources

216

Model parameters are detailed in Table 1. We used available published literature to

217

inform parameter estimates. We used the following publicly-available metrics for

218

model fitting: regional cumulative cases in SW England (tested and confirmed case in

219

hospital), and deaths (daily/cumulative counts) from the Public Health England

220

COVID-19 dashboard [14], and ONS weekly provisional data on COVID-19 related

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

221

deaths [25]. The case data is finalised prior to the previous five days, so we include all

222

data until 14th May 2020, based on data reported until 18th May 2020. The mortality

223

data from ONS does not explicitly state the number of COVID-19 related deaths

224

occurring in hospital, but they do report this value nationally (83.9% of COVID-19

225

deaths in hospital, as of 17th April 2020). We assume that this percentage applies to

226

the SW data and re-scale the mortality to 83.9% to represent an estimate of total

227

deaths in hospital.

228
229

Model calibration

230

Using the available data (Table 1), we define ranges for all parameters in our model

231

and sample all parameters simultaneously between these minimum and maximum

232

values assuming uniform distributions using Latin Hypercube Sampling (statistical

233

method for generating random parameters from multidimensional distribution), for a

234

total of 100,000 simulations. We used maximum likelihood estimation on total

235

cumulative cases and cumulative deaths with a Poisson negative log likelihood

236

calculated and summed over all observed and predicted points. For ğ‘– observed cases

237

ğ‘‹* (from data), and ğ‘– predicted cases ğ‘Œ* (from simulations of the model), we select the

238

best 100 parameter sets which maximise the log-likelihood âˆ‘ ğ‘‹* log(ğ‘Œ* ) âˆ’ ğ‘Œ* from the

239

total sample of 100,000 simulations. The best 100 samples were taken as part of a

240

bias-variance trade-off (Supplementary Information, Sensitivity analysis), and the

241

qualitative inferences would not change with other choices of sample size. For each

242

data point (taken from cases and deaths) we calculate this log-likelihood, and weight

243

each according to the square-root of the mean of the respective case or death data.

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

244

This ensures that we are considering case and death data equally within our likelihood

245

calculations.
Symbol
ğŸ/ğœ¼
ğœ¹
ğŸ/ğ
ğŸ/ğ†

ğœ¸ğ’ˆ

ğŸ/ğ
ğ

ğğ’ˆ

ğœ¿

school

distancing

lockdown

Description
Duration of the non-infectious
exposure period
Percentage of infections which
become symptomatic
Duration of symptoms whilst not
hospitalised (independent of
outcome)
Duration of stay in acute bed
(independent of outcome)
Percentage of symptomatic
cases which will require
hospitalisation

Uniform prior (min and max) or point estimate
5.1 days [26]
82.1% [27]; Vary between 73.15 â€“ 91.05%
Vary between 2 â€“ 14 days
Vary between 2 â€“ 14 days
0-4 = 0.00%, 5-17 = 0.0408%, 18-29 = 1.04%,
30-39 = 2.04-7.00%, 40-49 = 2.53-8.68%,
50-59 = 4.86-16.7%, 60-69 = 7.01-24.0%,
70+ = 9.87-37.6% [16]

Duration of stay in IC bed
(independent of outcome)
Percentage of those requiring
hospitalisation who will require
IC
Percentage of those requiring IC
who will die

3 â€“ 11 days [28]
Vary between 0 â€“ 30%
0-4 = 0.00%, 5-17 = 0.00%, 18-29 = 18.1%,
30-39 = 18.1%, 40-49 = 24.7%,
50-59 = 39.3%, 60-69 = 53.9%,
70+ = 65.3% [28]

Percentage of those requiring
acute beds (but not IC) who will
die
Percentage of 0-18-year olds
attending school after
23/03/2020
Percentage reduction in contact
rates due to social distancing
after 15/03/2020

Percentage reduction in contact
rates due to lockdown after
23/03/2020

Vary between 5 â€“ 35%

Assume 5%

Vary between 0 â€“ 50%
Retail/recreation: Bristol 86% Bath 90% Plymouth
85% Gloucs 84%, Somerset 82%, Devon 85%,
Dorset 84% [29]
Transit stations: Bristol 78% Bath 71% Plymouth
65% Gloucs 69%, Somerset 67%, Devon 66%,
Dorset 63% [29]
Vary between 63 - 90%

246

Initial reproductive number of
1.63 â€“ 3.95 [24]
COVID-19
Table 1: Parameter estimates used in the model and their sources. The distributions of unknown

247

parameters are shown in Figure S1 for the best 100 fits.

ğ‘¹ğŸ

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

248

Model outputs

249

For each of the 100 best parameter sets we run the model until 11th May 2020 and

250

output the cumulative cases and deaths in the SW. We output the predicted proportion

251

of the population who are infectious and who have ever been infected over time.

252

Finally, we estimate the daily and cumulative patterns of admission to and discharge

253

from hospital (intensive care and acute) and cumulative mortality from COVID-19.

254
255

Results and outputs

256

From 100,000 simulated parameter sets, we selected the best 100 baseline model fits

257

on the basis of agreement to the calibration data on daily confirmed COVID-19 cases

258

and weekly mortality due to COVID-19 in SW England. The distribution of the best

259

fitting values are shown in Figure S1a (and the priors in Figure S1b). All results are

260

shown with median and 95% credible intervals (95%CrI).

261
262

On 11th May 2020, the reported cumulative number of individuals with (lab confirmed)

263

COVID-19 was 7,116 in SW England [14], and the most recent report on total

264

cumulative deaths showed that 2,306 had died from COVID-19 (as of 8th May 2020)

265

[25].

266
267

Estimating the total proportion of individuals in South West England

268

with COVID-19

269

Figure 2 shows the projected numbers of exposed, recovered and infectious

270

(asymptomatic and symptomatic infections) until lockdown measures were lessened

271

on the 11th May 2020. On this date, the model predicts that a total of 5,793 (95%CrI

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

272

2,003 â€“ 12,051) were infectious (0.10% of the total SW England population, 95%CrI

273

0.04 â€“ 0.22%). The model also predicts that a total of 189,048 (95%CrI 141,580 â€“

274

277,955)

275

symptomatically), which is 3.4% (95%CrI 2.5 â€“ 5.0%) of the SW population (not

276

infectious and not susceptible to reinfection).

have

had

the

virus

but

recovered

(either

asymptomatically

or

277
278

Figure 2: The predicted median size of the exposed (E), infectious (I) and recovered classes (R), along

279

with the size of asymptomatic and symptomatic individuals on each day in SW England until 11th May

280

2020. Blue and red vertical lines represent the date the government introduced social distancing and

281

school closures/lockdown, respectively.

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

282

Estimating the total COVID-19 hospitalised patients in acute and

283

intensive care beds

284

The total number of patients in acute (non-intensive care) hospital beds across SW

285

England was projected to be 701 (95%CrI 169 â€“ 1,543) and the total number of

286

patients in intensive care hospital beds was projected to be 110 (95%CrI 8 â€“ 464) on

287

the 11th May 2020 (Figure 3). Note that these ranges are quite large due to the

288

uncertainty in the data and as more data becomes available these predictions will

289

change.

290
291

Figure 3: The predicted number of hospitalised patients in acute and intensive care beds in the SW

292

until 11th May 2020. The number of daily incoming patients diagnosed with COVID-19 are shown in

293

orange (from SW daily case data [14]), 95% credible intervals are shown in light grey, 50% in dark grey

294

and the median value of the fits is highlighted in black. The shaded region indicates the prediction of

295

the model from the data. Blue and red vertical lines represent the date the government introduced social

296

distancing, and school closures/lockdown, respectively.

297
298

Estimating the reproduction number under interventions

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

299

Figure 4 shows the model prediction for the reproduction (â€œRâ€) number over time until

300

11th May 2020, when lockdown measures were relaxed. All interventions (social

301

distancing, school closures/lockdown) had a significant impact on the reproductive

302

number for COVID-19 in the South West of England. We predict that prior to any

303

interventions R was 2.6 (95%CrI 2.0 â€“ 3.2), and the introduction of social distancing

304

reduced this number to 2.3 (95%CrI 1.8 â€“ 2.9). At the minimum, R was 0.6 (95%CrI

305

0.5 â€“ 0.7) after all prior interventions were enacted and adhered to (social distancing,

306

school closures and lockdown).

307
308

Figure 4: The effect of interventions on estimates of R (y-axis) over time until the 11th May 2020.

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

309
310

Discussion

311

We have developed a deterministic ordinary differential equation model of the

312

epidemic trajectory of COVID-19 focussing on acute and IC hospital bed capacity

313

planning to support local NHS authorities, calibrating to SW-specific data. The model

314

is age-structured and includes time-specific implementation of current interventions

315

(following advice and enforcement of social distancing, school closures and lockdown)

316

to predict the potential range of COVID-19 epidemic trajectories.

317

Using the publicly-available data on cases and deaths, combined with the early

318

estimates of parameters from early epidemics in other settings, we predict that on the

319

11th May 2020 a total of 5,793 (95%CrI 2,003 â€“ 12,051) were infectious, which equates

320

to 0.10% (95%CrI 0.04 â€“ 0.22%) of the total SW population. In addition, we find that

321

the model predicts a total of 189,048 (95%CrI 141,580 â€“ 277,955) have had the virus

322

but recovered, which is 3.4% (95%CrI 2.5 â€“ 5.0%) of the SW population.

323

We also estimate that the total number of patients in acute hospital beds in SW

324

England on 11th May 2020 was 701 (95%CrI 169 â€“ 1,543) and in IC were 110 (95%CrI

325

8 â€“ 464), while the R number has decreased from 2.6 (95%CrI 2.0 â€“ 3.2) to 0.6

326

(95%CrI 0.5 â€“ 0.7) after all interventions were enacted and fully adhered to.

327

The fits generally agree well with both the daily case data, and the cumulative

328

count of deaths in the SW, although the model overestimates the case data at early

329

stages, and underestimates later on (which can see seen in Figure S2a, and a scatter

330

plot of expected versus observed outputs in Figure S2b). This could be because we

331

are using formal fitting methods, or from the under-reporting of cases in the early

332

epidemic.

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

333

The primary strength of this study is that we have developed generalisable and

334

efficient modelling code incorporating disease transmission, interventions and hospital

335

bed demand which can be adapted for use in other regional or national scenarios, with

336

the

337

(github.com/rdbooton/bricovmod). We have worked closely with the NHS and at

338

Clinical Commissioning Group (CCG) level to ensure the model captures key clinical

339

features of disease management in SW hospitals and provides output data in a format

340

relevant to support local planning. We combined local clinical expertise with detailed

341

literature searches, to ensure reasonable parameter ranges and assumptions in the

342

presence of high levels of parameter uncertainty.

model

available

on

GitHub

for

open

review

and

use

343

The main challenge of this work is in balancing the urgent need locally for

344

prediction tools which are up to date (i.e. not relying on the national trends to inform

345

capacity planning), versus more exhaustive and robust methods for model

346

comparison. The latter of which uses existing models and more time-consuming (but

347

more robust) data fitting methods [30,31]. However, we believe that release of this

348

paper and sharing of model code will facilitate multidisciplinary collaboration, rapid

349

review and support future model comparison and uncertainty analyses [31].

350

As with all models of new infections there are significant parameter

351

uncertainties. Rapidly emerging literature is exploring a wide range of biological and

352

epidemiological factors concerning COVID-19, but due to the worldwide nature of

353

these studies, often parameter bands are wide and may be context specific. For

354

example, early estimates of the basic reproduction number ranged from 1.6 to 3.8 in

355

different locations [32,33], with an early estimate of 2.4 used in UK model projections

356

[8]. In addition, the information which informs our parameter selection is rapidly

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

357

evolving as new data is made available, sometimes on a daily basis. From our initial

358

analysis, we identified the following parameters as critical in determining the epidemic

359

trajectory within our model â€“ the percentage of infections which become symptomatic,

360

the recovery time for cases which do not require hospital, the period between acute

361

and IC occupancy, the length of stay in IC, the probability of transmission per contact

362

and the gradual implementation of lockdown rather than immediate effect. Other

363

parameters (such as the percentage reduction in school-age contacts from school

364

closures) did not seem to influence the dynamic trajectory as strongly â€“ and thus we

365

assume point estimates for these parameters. However, for example assuming that

366

95% of school-age contacts are reduced as a direct result of school closures is

367

perhaps an overestimate, and future modelling work should address these

368

uncertainties and their impacts on the epidemic trajectory of COVID-19 (but in this

369

case, this value was somewhat arbitrary, and the assumption was used in the absence

370

of school-age contact survey data). More research is urgently needed to refine these

371

parameter ranges and to validate these biological parameters experimentally.

372

We have also assumed that there is no nosocomial transmission of infection

373

between hospitalised cases and healthcare workers, as we do not have good data for

374

within-hospital transmission. However frontline healthcare staff were likely to have

375

been infected early on in the epidemic [34], which could have implications for our

376

predicted epidemic trajectory. Our model also assumes a closed system, which may

377

not strictly be true due to continuing essential travel. But given that up until 11th May,

378

travel restrictions are very severe due to lockdown measures [5], any remaining inter-

379

regional travel is likely to have minimal effects on our model outputs.

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

380

Similar to most other COVID-19 models, we use a variant on a susceptible-

381

exposed-infectious-recovered (SEIR) structure [8â€“10,16,30,35,36]. We do not

382

spatially structure the population as in other UK modelling [9,10], but we do include

383

age-specific mixing based on POLYMOD data [22], and the post-lockdown CoMix

384

study [11]. We also explicitly measure the total asymptomatic infection, and the total

385

in each of the clinically relevant hospital classes (acute or IC), which is a strength of

386

our approach. Future models could also take into account local bed capacity within

387

hospitals (including Nightingale centres) and accommodate the effect of demand

388

outstripping supply leading to excess deaths, inclusive of non-hospital-based death

389

such as is occurring within care homes. As with all modelling, we have not taken into

390

account all possible sources of modelling misspecification. Some of these

391

misspecifications will tend to increase the predicted epidemic period, and others will

392

decrease it. One factor that could significantly change our predicted epidemic period

393

is the underlying structure within the population leading to heterogeneity in the average

394

number of contacts under lockdown e.g. key workers have high levels of contact but

395

others are able to minimise contacts effectively, this might lead to an underestimate of

396

ongoing transmission, but potentially an overestimate of the effect of releasing

397

lockdown. We also know that there are important socio-economic considerations in

398

determining peopleâ€™s ability to stay at home and particularly to work from home [37].

399

Early UK modelling predicted the infection peak to be reached roughly 3 weeks

400

from the initiation of severe lockdown measures, as taken by the UK government in

401

mid-March [8]. A more recent study factoring spatial distribution of the population

402

indicated the peak to follow in early April due to ğ‘…- reducing to below 1 in many settings

403

in weeks following lockdown [9]. Other modelling indicated that deaths in the UK would

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

404

peak in mid-late April; furthermore, that the UK would not have enough acute and IC

405

beds to meet demand [38]. While modelling from the European Centre for Disease

406

Prevention and Control estimated peak cases to occur in most Euopean countries in

407

mid-April [20], these estimations were largely at a national level. Due to the expected

408

lag of other regions behind London, these estimated peaks are likely to be shifted

409

further into the future for the separate regions of the UK, and as shown by our model

410

occurred in early- to mid-April. This is also likely to be true for future peaks which may

411

result from relaxing lockdown.

412

Outside of the UK, similar modelling from France [35] (which went into lockdown

413

at a similar time the UK on 17th March), predicted the peak in daily IC admissions at

414

the end of March. Interestingly however, when dissected by region, the peak in IC bed

415

demand varied by roughly 2 weeks. Swiss modelling similarly predicted a peak in

416

hospitalisation and numbers of patients needing IC beds in early April, after lockdown

417

implementation commenced on 17th March [36]. US modelling [39] disaggregated by

418

State, also highlights the peak of excess bed demand varies geographically, with this

419

peak ranging between the 2nd week of April, through to May dependent on the State

420

under consideration. The modelling based in France also cautioned that due to only

421

5.7% of the population having been infected by 11th May when the restrictions would

422

be eased, the population would be vulnerable to a second epidemic peak thereafter

423

[35].

424

The ONS in England estimated that an average of 0.25% of the population had

425

COVID-19 between the 4th and 17th May 2020 (95% confidence interval: 0.16 â€“ 0.38%)

426

[40], which is greater than the 0.10% (95%CrI 0.04 â€“ 0.22%) we found with our model

427

(on 11th May 2020), but with some overlap. In addition, the ONS estimated that 6.78%

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

428

(95%CrI 5.21 â€“ 8.64%) tested positive for antibodies to COVID-19 up to 24th May 2020

429

in England [41], and Public Health England estimated that approximately 4% (2 â€“ 6%)

430

tested positive for antibodies to COVID-19 between the 20th and 26th April 2020 in

431

the SW [42]. Comparing to our model, 3.4% (95%CrI 2.5 â€“ 5.0%) had recovered on

432

the 11th May 2020 (2 weeks later), demonstrating that our model estimates may be

433

within sensible bounds, and further highlighting the need for more regional estimates

434

of crucial epidemiological parameters and seroprevalence. We have assumed that

435

individuals are not susceptible to reinfection within the model timeframe, however in

436

future work it will be important to explore this assumption. It is not known what the long

437

term pattern of immunity to COVID-19 will be [43], and this will be key to understanding

438

the future epidemiology in the absence of a vaccine or effective treatment options.

439

With this in mind, our findings demonstrate that there are still significant data

440

gaps â€“ and in the absence of such data, mathematical models can provide a valuable

441

asset for local and regional healthcare services. This regional model will be used

442

further in the SW as the pandemic evolves and could be used within other healthcare

443

systems in other geographies to support localised predictions. Controlling intervention

444

measures at a more local level could be made possible through monitoring and

445

assessment at the regional level through a combination of clinical expertise and local

446

policy, guided by localised predictive forecasting as presented in this study.

447
448

Funding statement

449

This work was funded with support from the Elizabeth Blackwell Institute, Bristol

450

UNCOVER (Bristol COVID Emergency Research) and Medical Research Council

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

451

UK. LM, KJL, EBP and KMET acknowledge support from the NIHR Health Protection

452

Research Unit in Behavioural Science and Evaluation at the University of Bristol.

453

This work was also supported by Health Data Research UK, which is funded by the

454

UK Medical Research Council, Engineering and Physical Sciences Research

455

Council, Economic and Social Research Council, National Institute for Health

456

Research, Chief Scientist Office of the Scottish Government Health and Social Care

457

Directorates, Health and Social Care Research and Development Division (Welsh

458

Government), Public Health Agency (South Western Ireland), British Heart

459

Foundation and Wellcome.

460
461

Competing interests statement

462

We declare no competing interests.

463
464

Author contributions

465

Conception and design of the study: LD, EBP. Acquisition of data: RDB, EBP, RW,

466

KMET. Mathematical modelling: RDB, LM, LD, EBP, RW, KMET. Coding and

467

simulations: RDB. Analysis and interpretation of results: RDB, LM, LV, KJL, CH, PB,

468

IH, RL, FH, DL, LD, AP, EBP, RW, KMET. Writing and drafting of the manuscript:

469

RDB, LM, LV, KJL, CH, PB, IH, RL, FH, DL, LD, AP, EBP, RW, KMET. Approval of

470

the submitted manuscript: RDB, LM, LV, KJL, CH, PB, IH, RL, FH, DL, LD, AP, EBP,

471

RW, KMET.

472
473

Data sharing statement

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

474

All model code is open source and available for download on GitHub

475

https://github.com/rdbooton/bricovmod. All data is freely available via the GOV.UK

476

COVID-19 dashboard [14] and ONS [21,25].

477
478
479
480
481

References

482

1.

World Health Organization. WHO Director-Generalâ€™s opening remarks at the

483

mission briefing on COVID-19. 2020 [cited 27 Apr 2020]. Available:

484

https://www.who.int/dg/speeches/detail/who-director-general-s-opening-

485

remarks-at-the-media-briefing-on-covid-19---11-march-2020

486

2.

487

Johns Hopkins University. COVID-19 Data Center. COVID-19 Case Tracker.
[cited 27 Apr 2020]. Available: https://coronavirus.jhu.edu/

488

3.

Payne C. State intervention in China. Nat Hum Behav. 2020;1.

489

4.

Public Health Agency of Sweden. Public Health Authority regulations and

490

general advice on everyoneâ€™s responsibility to prevent the infection of COVID-

491

19. 2020 [cited 7 Apr 2020]. Available:

492

https://www.folkhalsomyndigheten.se/publicerat-

493

material/publikationsarkiv/h/hslf-fs-202012/

494

5.

Public Health England. Guidance on social distancing for everyone in the UK.

495

In: Guidance on social distancing for everyone in the UK [Internet]. 2020 [cited

496

27 Apr 2020]. Available: https://www.gov.uk/government/publications/covid-19-

497

guidance-on-social-distancing-and-for-vulnerable-people/guidance-on-social-

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

498

distancing-for-everyone-in-the-uk-and-protecting-older-people-and-vulnerable-

499

adults

500

6.

Prem K, Liu Y, Russell TW, Kucharski AJ, Eggo RM, Davies N, et al. The

501

effect of control strategies to reduce social mixing on outcomes of the COVID-

502

19 epidemic in Wuhan, China: a modelling study. Lancet Public Heal. 2020.

503

7.

Flaxman S, Mishra S, Gandy A, Unwin JT, Coupland H, Mellan TA, et al.

504

Estimating the number of infections and the impact of non-pharmaceutical

505

interventions on COVID-19 in 11 European countries. Imp Coll London

506

COVID-19 Report No 13. 2020.

507

8.

Ferguson NM, Laydon D, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie

508

MB, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma CucunubÃ¡, Gina Cuomo-

509

Dannenburg, Amy Dighe I, Dorigatti, Han Fu, Katy Gaythorpe, Will Green,

510

Arran Hamlet, Wes Hinsley, Lucy C Okell S van, Elsland, Hayley Thompson,

511

Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang PGW, et al. Impact of

512

non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and

513

healthcare demand. Imp Coll London COVID-19 Report No 9. 2020.

514

9.

Challen R, Tsaneva-Atanasova K, Pitt M. Estimates of regional infectivity of

515

COVID-19 in the United Kingdom following imposition of social distancing

516

measures. medRxiv. 2020.

517

10.

Danon L, Brooks-Pollock E, Bailey M, Keeling MJ. A spatial model of CoVID-

518

19 transmission in England and Wales: early spread and peak timing.

519

medRxiv. 2020.

520
521

11.

Jarvis CI, Zandvoort K Van, Gimma A, Prem K, Group CC-19 working, Klepac
P, et al. Quantifying the impact of physical distance measures on the

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

522
523

transmission of COVID-19 in the UK. medRxiv. 2020.
12.

The Novel Coronavirus Pneumonia Emergency Response Epidemiology

524

Team. The epidemiological characteristics of an outbreak of 2019 novel

525

coronavirus diseases (COVID-19) â€” China, 2020. Chin J Epidemiol. 2020;41.

526

13.

Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of

527

patients dying in relation to COVID-19 in Italy. JAMA - Journal of the American

528

Medical Association. 2020.

529

14.

530
531

Public Health England. Coronavirus (COVID-19) in the UK: data dashboard.
2020 [cited 28 Apr 2020]. Available: https://coronavirus.data.gov.uk/#

15.

Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of

532

critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-

533

centered, retrospective, observational study. Lancet Respir Med. 2020.

534

16.

Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al. Estimates

535

of the severity of coronavirus disease 2019 : a model-based analysis. Lancet

536

Infect Dis. 2020.

537

17.

McCurdy C. Ageing, fast and slow: when place and demography collide.

538

Resolut Found. 2019. Available:

539

https://wwwresolutionfoundationorg/app/uploads/2019/10/Ageing-fast-and-

540

slowpdf

541

18.

Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of

542

comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a

543

systematic review and meta-analysis. Int J Infect Dis. 2020.

544
545

19.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors
for mortality of adult inpatients with COVID-19 in Wuhan, China: a

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

546
547

retrospective cohort study. Lancet. 2020.
20.

Stockholm: ECDC (European Centre for Disease Prevention and Control).

548

Coronavirus disease 2019 (COVID-19) pandemic: increased transmission in

549

the EU/EEA and the UK â€“ seventh update, 25 March 2020. 2020. Available:

550

https://www.ecdc.europa.eu/sites/default/files/documents/RRA-seventh-

551

update-Outbreak-of-coronavirus-disease-COVID-19.pdf

552

21.

Office for National Statistics. Estimates of the population for the UK, England

553

and Wales, Scotland and Northern Ireland. 2020. Available:

554

https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigratio

555

n/populationestimates/datasets/populationestimatesforukenglandandwalesscot

556

landandnorthernireland

557

22.

Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, et al. Social

558

contacts and mixing patterns relevant to the spread of infectious diseases.

559

PLoS Med. 2008. doi:10.1371/journal.pmed.0050074

560

23.

Stedman M, Davies M, Anderson SG, Lunt M, Verma A, Heald A. A phased

561

approach to unlocking during the COVID-19 pandemic; Lessons from trend

562

analysis. medRxiv. 2020. doi:10.1101/2020.04.20.20072264

563

24.

Liu Y, Gayle AA, Wilder-Smith A, RocklÃ¶v J. The reproductive number of

564

COVID-19 is higher compared to SARS coronavirus. J Travel Med. 2020;27.

565

doi:10.1093/jtm/taaa021

566

25.

Office for National Statistics. Deaths registered in England and Wales,

567

provisional 2020: up to week ending 17 April 2020. 2020. Available:

568

https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarria

569

ges/deaths/datasets/weeklyprovisionalfiguresondeathsregisteredinenglandand

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

570
571

wales
26.

Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The

572

incubation period of coronavirus disease 2019 (COVID-19) from publicly

573

reported confirmed cases: estimation and application. Ann Intern Med. 2020.

574

27.

Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic

575

proportion of coronavirus disease 2019 (COVID-19) cases on board the

576

Diamond Princess cruise ship, Yokohama, Japan, 2020. Eurosurveillance.

577

2020.

578

28.

ICNARC COVID-19 study case mix programme database. ICNARC report on

579

COVID-19 in critical care 15 May 2020. 2020. Available:

580

https://www.icnarc.org/Our-Audit/Audits/Cmp/Reports

581

29.

Google. United Kingdom COVID-19 Community Mobility Report: Mobility

582

changes April 5 2020. 2020. Available:

583

https://www.gstatic.com/covid19/mobility/2020-04-

584

05_GB_Mobility_Report_en.pdf

585

30.

Wynants L, Van Calster B, Bonten MMJ, Collins GS, Debray TPA, De Vos M,

586

et al. Prediction models for diagnosis and prognosis of covid-19 infection:

587

systematic review and critical appraisal. BMJ. 2020.

588

31.

Latif S, Usman M, Manzoor S, Iqbal W, Qadir J, Tyson G, Castro I, Razi A,

589

Boulos MN CJ. Leveraging Data Science To Combat COVID-19: A

590

Comprehensive Review. 2020.

591

32.

Kucharski AJ, Russell TW, Diamond C, Liu Y, Edmunds J, Funk S, et al. Early

592

dynamics of transmission and control of COVID-19: a mathematical modelling

593

study. Lancet Infect Dis. 2020.

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

594

33.

Read JM, Bridgen JRRE, Cummings DATA, Ho A, Jewell CP. Novel

595

coronavirus 2019-nCoV: early estimation of epidemiological parameters and

596

epidemic predictions. medRxiv. 2020.

597

34.

The Centre for Evidence-Based Medicine Website. How many healthcare

598

workers are infected? 2020 [cited 23 Apr 2020]. Available:

599

https://wwwcebmnet/covid-19/covid-19-how-many-healthcare-workers-are-

600

infected/

601

35.

602
603

Salje H, Kiem C, Lefrancq N, Courtejoie N, Bosetti P. Estimating the burden of
SARS-CoV-2 in France. HAL ID pasteur-02548181. 2020.

36.

Althaus C. Real-time modeling and projections of the COVID-19 epidemic in

604

Switzerland. Inst Soc Prev Med Univ Bern, Switz. 2020. Available:

605

https://ispmberngithubio/covid-19/swiss-epidemic-model/

606

37.

607
608

Dingel J, Neiman B. How Many Jobs Can be Done at Home? NBER Work
Pap. 2020.

38.

Institute for Health Metrics and Evaluation. New COVID-19 forecasts for

609

Europe: Italy & Spain have passed the peak of their epidemics; UK, early in its

610

epidemic, faces a fast-mounting death toll. 2020. Available:

611

http://www.healthdata.org/news-release/new-covid-19-forecasts-europe-italy-

612

spain-have-passed-peak-their-epidemics-uk-early-its

613

39.

IHME COVID-19 health service utilization forecasting team. Forecasting

614

COVID-19 impact on hospital bed-days, ICU-days, ventilator-days and deaths

615

by US state in the next 4 months. medxriv. 2020.

616
617

40.

ONS. Coronavirus (COVID-19) Infection Survey pilot: England, 21 May 2020.
2020.

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

618

41.

ONS. Coronavirus (COVID-19) Infection Survey pilot: 28 May 2020. 2020.

619

42.

Public Health England. Weekly Coronavirus Disease 2019 (COVID-19)

620

Surveillance Report, Week 22. 2020. Available:

621

https://assets.publishing.service.gov.uk/government/uploads/system/uploads/a

622

ttachment_data/file/888254/COVID19_Epidemiological_Summary_w22_Final.

623

pdf

624
625
626
627
628

43.

Altmann DM, Douek DC, Boyton RJ. What policy makers need to know about
COVID-19 protective immunity. The Lancet Comments. 2020.

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

629

Supplementary information
Population size SW

Percent population

Percent population

England

size SW England

size UK

0-4

296,357

5.3%

6.0%

5-18

805,965

14.4%

15.4%

18-29

806,885

14.4%

15.4%

30-39

654,469

11.7%

13.4%

40-49

684,872

12.2%

12.8%

50-59

782,317

14.0%

13.4%

60-69

671,294

12.0%

10.5%

70+

897,576

16.0%

13.1%

Age group

630
631
632
633
634
635
636
637

Table S1: Demography of SW England compared to the UK.

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

638

Key assumptions used in the model

639
640

i.

Closed, static population size with no immigration or emigration due to

641

the model being run over a short period of time, and current travel restrictions which

642

should prevent significant movement of individuals in and out of the South West.

643

ii.

No nosocomial transmission.

644

iii.

Recovered individuals are not susceptible to reinfection within the timeframe of

645
646

the model horizon.
iv.

647

Trajectory of model outputs is assuming that there is no easing of lockdown situation
over the timeframe of the model horizon.

648

v.

There is no restriction on number of hospital (IC and acute) beds available.

649

vi.

Asymptomatic and symptomatic are equally infectious and recover at the same rate.

650

vii.

95% reduction in 0-18-year old contacts from school closures

651

viii.

Range of 0 - 50% reduction in contacts from social distancing and range of 63 - 90%

652
653

reduction in contact rates due to lockdown
ix.

654
655

school closures and social distancing.
x.

656
657

R_0 is sampled between 2.79 +/- 1.16 and the infectious period and transmission
probability are chosen to achieve this

xi.

658
659

The reduction of any given contact rate is taken to be the minimum from lockdown,

Proportion symptomatic which require hospitalisation depends on age, with increased
risk for older age groups

xii.

660

Proportion in IC who will die depends on age, with increased risk for older age
groups

661

xiii.

The percentage of infections which become symptomatic is 73.15 - 91.05%

662

xiv.

The percentage of those requiring hospital who will require IC 0 - 30%

663

xv.

The percentage of those requiring acute beds (but not IC) who will die 5 - 35%

664

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

665
666

Figure S1a: The distribution of the best 100 parameters selected for in the Latin Hypercube Sampling

667

and likelihood fitting from 100,000 simulations.

668

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

669
670

Figure S1b: The distribution of the uniform priors in the Latin Hypercube Sampling from 100,000

671

samples.

672

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

673
674

Figure S2a: Fitting performance of the model. The cumulative case numbers and hospital deaths for

675

COVID-19 in SW England until lockdown measures were gradually lifted (11th May 2020), based on

676

case data and death data (orange). 95% credible intervals of our model projections are shown in light

677

grey, 50% in dark grey and the median value of the model is highlighted in black. The shaded region

678

indicates the prediction of the model from the data. We did not consider the effects of lockdown being

679

lifted, and our transmission rates are fitted to both before lockdown and after lockdown. Blue and red

680

vertical lines represent the dates when social distancing and school closures/lockdown were introduced

681

nationally, respectively.

682

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

683
684

Figure S2b: The expected (model) versus observed (data) for the median of 100 fits, and all 100 fits

685

for counts of daily case numbers. The model tends to overestimate the case data at earlier stages of

686

the epidemic and underestimate at later stages of the epidemic.

687
688
689
690

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

691

Sensitivity analysis

692

The choice of the final sample size m=100 taken from 100k samples is based on a

693

bias-variance trade-off with lower m giving a better model fit but higher m allowing

694

more predictions to be included. The choice of m is not of practical significance for the

695

median and 95% credible intervals of the main outcome measures of the model â€“ bed

696

modelling - as shown in the below table.
Median (95% CrI) value on 11th May 2020

Size of final sample size from

Total recovered

Total infectious

Total in acute beds

Total in IC beds

50

191k (143k â€“ 276k)

5k (2k â€“ 10k)

579 (152 â€“ 1424)

107 (14 â€“ 497)

100

189k (142k â€“ 278k)

6k (2k â€“ 12k)

701 (169 â€“ 1543)

110 (8 â€“ 464)

200

189k (141k - 276k)

6k (2k â€“ 16k)

709 (171 â€“ 1564)

105 (5 â€“ 454)

500

191k (132k â€“ 289k)

7k (2k â€“ 20k)

690 (171 â€“ 1644)

109 (5 â€“ 426)

100k samples

697
698

Increasing m does slightly increase the estimate of the infectious population (total

699

infectious). This is explained by including models with slightly higher R value, i.e. R is

700

biased upwards as we move further away from the best answer. The bias is small

701

compared to the modelling uncertainty.
Median (95% CrI) of parameter

Size of final

R

ğ›¿

1/ğœ‡

1/ğœŒ

1/ğœ“

ğœ–

ğœ…

endphase

2.5 (2.1 - 3.1)

82 (74 â€“ 90%)

3.9 (2.6 â€“

6.3 (2.4 â€“

6.5 (2.6 â€“

19 (4 â€“

29 (19 â€“

21.3 (11.1 â€“

5.8)

13.1)

13.8)

28%)

34%)

30.0)

4.3 (2.5 â€“

7.7 (2.3 â€“

6.7 (2.5 â€“

16 (2 â€“

28 (19 â€“

19.7 (10.8 â€“

6.0)

13.3)

13.8)

30%)

34%

30.0)

4.5 (2.4 â€“

7.8 (2.3 â€“

6.7 (2.4 â€“

16 (1 â€“

28 (17 â€“

18.5 (8.6 â€“

6.7)

13.6)

13.8)

30%)

34%)

30.3)

5.0 (2.5 â€“

7.3 (2.4 â€“

7.2 (2.5 â€“

17 (1 â€“

28 (15 â€“

18.3 (6.4 â€“

8.3)

13.6)

13.8)

29%)

35%)

30.3)

sample size from
100k samples

50

100

200

500

702

2.6 (2.1 - 3.2)

2.6 (2.1 - 3.3)

2.7 (2.1 - 3.5)

82 (74 â€“ 90%)

82 (74 â€“ 91%)

82 (74 â€“ 90%)

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20084715; this version posted June 12, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

703

The inverse of ğœ‡ and

704

sample size becomes larger. This then reduces the parameters endphase,

705

ğœ…, and ğœ– in order to account for this bias in R.

ğœ“

becomes bigger (as it is related to the selection of R), as the

706
707

We choose to report values for m=100 samples as part of the bias-variance trade-off.

708

The bias is small for this choice, with R close to unbiased and the confidence

709

intervals capture all of the significant variation components. The qualitative

710

inferences would not change with any of the above choices of m and uncertainty has

711

been well captured.

